153 related articles for article (PubMed ID: 30451050)
1. Bioactive metabolites from the leaves of Withania adpressa.
Ben Bakrim W; El Bouzidi L; Nuzillard JM; Cretton S; Saraux N; Monteillier A; Christen P; Cuendet M; Bekkouche K
Pharm Biol; 2018 Dec; 56(1):505-510. PubMed ID: 30451050
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effects of withanolides from Withania adpressa.
Abdeljebbar LH; Benjouad A; Morjani H; Merghoub N; El Haddar S; Humam M; Christen P; Hostettmann K; Bekkouche K; Amzazi S
Therapie; 2009; 64(2):121-7. PubMed ID: 19664406
[TBL] [Abstract][Full Text] [Related]
3. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
Nile SH; Nile A; Gansukh E; Baskar V; Kai G
Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A-related steroids from Withania aristata exhibit potent antiproliferative activity by inducing apoptosis in human tumor cells.
Llanos GG; Araujo LM; Jiménez IA; Moujir LM; Bazzocchi IL
Eur J Med Chem; 2012 Aug; 54():499-511. PubMed ID: 22705001
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic withanolides from the leaves of Moroccan Withania frutescens.
El Bouzidi L; Mahiou-Leddet V; Bun SS; Larhsini M; Abbad A; Markouk M; Fathi M; Boudon M; Ollivier E; Bekkouche K
Pharm Biol; 2013 Aug; 51(8):1040-6. PubMed ID: 23742647
[TBL] [Abstract][Full Text] [Related]
6. Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells.
Singh D; Aggarwal A; Maurya R; Naik S
Phytother Res; 2007 Oct; 21(10):905-13. PubMed ID: 17562568
[TBL] [Abstract][Full Text] [Related]
7. Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation.
Mulabagal V; Subbaraju GV; Rao CV; Sivaramakrishna C; Dewitt DL; Holmes D; Sung B; Aggarwal BB; Tsay HS; Nair MG
Phytother Res; 2009 Jul; 23(7):987-92. PubMed ID: 19152372
[TBL] [Abstract][Full Text] [Related]
8. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
9. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationships of Withanolides as Antiproliferative Agents for Multiple Myeloma: Comparison of Activity in 2D Models and a 3D Coculture Model.
Freitas Misakyan MF; Wijeratne EMK; Issa ME; Xu YM; Monteillier A; Gunatilaka AAL; Cuendet M
J Nat Prod; 2021 Aug; 84(8):2321-2335. PubMed ID: 34445874
[TBL] [Abstract][Full Text] [Related]
11. Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopy.
Namdeo AG; Sharma A; Yadav KN; Gawande R; Mahadik KR; Lopez-Gresa MP; Kim HK; Choi YH; Verpoorte R
Planta Med; 2011 Nov; 77(17):1958-64. PubMed ID: 21728148
[TBL] [Abstract][Full Text] [Related]
12. Biologically active withanolides from Withania coagulans.
Ihsan-ul-Haq ; Youn UJ; Chai X; Park EJ; Kondratyuk TP; Simmons CJ; Borris RP; Mirza B; Pezzuto JM; Chang LC
J Nat Prod; 2013 Jan; 76(1):22-8. PubMed ID: 23316950
[TBL] [Abstract][Full Text] [Related]
13. Effect of Geographical Location and Type of Extract on Total Phenol/Flavon Contents and Antioxidant Activity of Different Fruits Extracts of Withania somnifera.
Adhikari L; Kotiyal R; Pandey M; Bharkatiya M; Sematy A; Semalty M
Curr Drug Discov Technol; 2020; 17(1):92-99. PubMed ID: 30084332
[TBL] [Abstract][Full Text] [Related]
14. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
15. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
16. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
17. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive withanolides from Withania coagulans.
Huang CF; Ma L; Sun LJ; Ali M; Arfan M; Liu JW; Hu LH
Chem Biodivers; 2009 Sep; 6(9):1415-26. PubMed ID: 19774603
[TBL] [Abstract][Full Text] [Related]
19. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
